Novo's Worst Year Is Your Best Opportunity

On the surface, Novo Nordisk ( NVO ) looks like a great "growth at a reasonable price" opportunity (aka GARP) because its fundamentals keep improving, and the stock price still can't find its bottom, updating new lowsA seasoned consulting specialist at a leading Central Asian bank. The author behind Novo Capital brings half a decade of experience delivering strategic insight and analysis for the bank's clientele within the private banking branch. Launching the career back in 2020 after graduating from a top ...